Molina Healthcare posts Q4 loss and guides 2026 adjusted EPS to at least $5.00
Molina Healthcare reported a fourth-quarter 2025 GAAP loss of $3.15 per diluted share and full-year 2025 adjusted earnings of $11.03 per share, down 51% from the prior year. For 2026, it guided to adjusted earnings of at least $5.00 per diluted share and premium revenue of about $42 billion, a roughly 2% decline, and said it will exit its traditional Medicare Advantage Part D product for 2027.
Key points
- Q4 2025 GAAP loss of $3.15 per diluted share and adjusted loss of $2.75, burdened by about $2.00 of unfavorable retroactive revenue items
- Full-year 2025 total revenue of $45.4 billion, up from $40.7 billion, while GAAP EPS fell to $8.92 from $20.42
- 2026 guidance: GAAP EPS of at least $3.20 and adjusted EPS of at least $5.00, burdened by $2.50 per share from a new Florida Medicaid contract and the Part D product
- Company will exit the MAPD product, which has about $1 billion in annual premium, for 2027
The filing
Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.